The global Oncology Injection Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Oncology Injection Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncology Injection Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oncology Injection Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oncology Injection Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Organs
Central Nervous System
Circulatory/Musculoskeletal System

Segment by Application
Lymphoma
Myeloma
Prostate Cancer